03/11/2024
Acetazolamide is one of the main medicines used in the treatment of idiopathic intracranial hypertension. Pharmac has began consultation on a potential brand change for acetazolamide through the 2023/24 Invitation to Tender.
Consultation on a potential brand change for acetazolamide 27 September 2024 What we’re seeking feedback on We are seeking feedback from people about a potential brand change for acetazolamide tablets. Acetazolamide 250 mg tablets (branded as Diamox) are currently supplied by Arrotex Pharmaceutica...
